jasminum officinale flower/leaf extract hamilelikte güvenli mi?
No harmonised reproductive classification found (no H360/H361 in ECHA Annex VI) and no SCCS or CIR reproductive safety warning specific to Jasminum officinale flower/leaf extract. Literature and regulatory sources do not report reproductive or teratogenic effects for the botanical extract; therefore default hazard and mechanism are 0. Topical cosmetics can give low but measurable dermal exposure to botanical extracts (CosIng / PubChem use data), so exposure is scored as low (1). Sources: ECHA Annex VI (no harmonised CLP for this ingredient), CosIng / PubChem, absence of CIR or SCCS repro findings.
Pregnancy-safe products containing jasminum officinale flower/leaf extract










Related ingredients
Frequently asked questions
- jasminum officinale flower/leaf extract hamilelikte güvenli mi?
- No harmonised reproductive classification found (no H360/H361 in ECHA Annex VI) and no SCCS or CIR reproductive safety warning specific to Jasminum officinale flower/leaf extract. Literature and regulatory sources do not report reproductive or teratogenic effects for the botanical extract; therefore default hazard and mechanism are 0. Topical cosmetics can give low but measurable dermal exposure to botanical extracts (CosIng / PubChem use data), so exposure is scored as low (1). Sources: ECHA Annex VI (no harmonised CLP for this ingredient), CosIng / PubChem, absence of CIR or SCCS repro findings.
- jasminum officinale flower/leaf extract emzirirken güvenli mi?
- No evidence of reproductive/ developmental toxicity or lactation transfer reported in SCCS/CIR or peer‑reviewed literature for this extract. Systemic absorption from typical topical cosmetic use is low but measurable, so breastfeeding exposure is scored as low (1). Sources: CIR (no specific restriction), CosIng, PubChem.
- jasminum officinale flower/leaf extract bebek cildi için güvenli mi?
- No infant‑specific reproductive or developmental hazards identified. Mechanistic data lacking. Because infants (0–3 yr) have higher dermal absorption and surface‑area‑to‑weight ratio, exposure score is increased by +1 relative to adults (adult e=1 → infant e=2). Note: this does not indicate intrinsic reproductive hazard but reflects higher potential exposure through immature skin. Sources: CosIng, PubChem, general toxicological principles on infant skin permeability.
- VeriMom jasminum officinale flower/leaf extract nasıl puanlıyor?
- VeriMom jasminum officinale flower/leaf extract'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte jasminum officinale flower/leaf extract yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.